SCM
Silverarc Capital Management Portfolio holdings
AUM
$489M
This Quarter Return
+19.76%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$489M
AUM Growth
+$489M
(+2.1%)
Cap. Flow
-$56.8M
Cap. Flow
% of AUM
-11.63%
Top 10 Holdings %
Top 10 Hldgs %
54.97%
Holding
83
New
12
Increased
18
Reduced
24
Closed
22
Top Buys
| 1 |
CG Oncology
CGON
|
$14.1M |
| 2 |
Scholar Rock
SRRK
|
$12.1M |
| 3 |
Neurocrine Biosciences
NBIX
|
$11.4M |
| 4 |
Vaxcyte
PCVX
|
$9.36M |
| 5 |
UroGen Pharma
URGN
|
$8.79M |
Top Sells
| 1 |
VRNA
Verona Pharma
VRNA
|
$17.7M |
| 2 |
Nuvalent
NUVL
|
$15.5M |
| 3 |
Disc Medicine
IRON
|
$11.7M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$8.49M |
| 5 |
Wave Life Sciences
WVE
|
$8.49M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Communication Services | 0% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Abeona Therapeutics
ABEO
$353M
| $5.21M | 0.96% |
+917,898
| New | +$5.21M |
|
27
Cidara Therapeutics
CDTX
$1.62B
| $5.06M | 0.93% |
+103,943
| New | +$5.06M |
|
28
Celldex Therapeutics
CLDX
$1.48B
| $4.04M | 0.74% |
198,441
-7,521
| -4% | -$153K |
|
|
AARD
29
Aardvark Therapeutics, Inc. Common Stock
AARD
$189M
| $3.88M | 0.72% |
286,807
+167,311
| +140% | +$2.26M |
|
30
MoonLake Immunotherapeutics
MLTX
$3.63B
| $3.87M | 0.71% |
+82,023
| New | +$3.87M |
|
|
31
Syndax Pharmaceuticals
SNDX
$1.38B
| $3.77M | 0.7% |
402,964
-906,260
| -69% | -$8.49M |
|
32
Structure Therapeutics
GPCR
$1.13B
| $3.64M | 0.67% |
175,636
-12,433
| -7% | -$258K |
|
33
Cerus
CERS
$245M
| $3.51M | 0.65% |
2,488,291
+31,754
| +1% | +$44.8K |
|
34
Erasca
ERAS
$454M
| $3.26M | 0.6% |
2,569,591
-4,798,405
| -65% | -$6.09M |
|
35
Compass Therapeutics
CMPX
$473M
| $3.25M | 0.6% |
1,249,781
+374,912
| +43% | +$975K |
|
|
SION
36
Sionna Therapeutics, Inc. Common Stock
SION
$1.1B
| $3.23M | 0.6% |
186,015
+71,877
| +63% | +$1.25M |
|
37
Benitec Biopharma
BNTC
$355M
| $2.96M | 0.55% |
253,234
+3,234
| +1% | +$37.8K |
|
38
Trevi Therapeutics
TRVI
$884M
| $2.95M | 0.54% |
539,587
+9,587
| +2% | +$52.4K |
|
39
uniQure
QURE
$909M
| $2.82M | 0.52% |
202,565
-835
| -0.4% | -$11.6K |
|
40
Kiniksa Pharmaceuticals
KNSA
$2.51B
| $2.1M | 0.39% |
75,959
-12,256
| -14% | -$339K |
|
|
ORKA
41
Oruka Therapeutics, Inc. Common Stock
ORKA
$570M
| $1.85M | 0.34% |
+165,389
| New | +$1.85M |
|
42
Dianthus Therapeutics
DNTH
$776M
| $1.78M | 0.33% |
95,806
-94,528
| -50% | -$1.76M |
|
43
Tourmaline Bio
TRML
$593M
| $1.75M | 0.32% |
+109,257
| New | +$1.75M |
|
44
Mineralys Therapeutics
MLYS
$1.87B
| $1.56M | 0.29% |
115,282
-223,072
| -66% | -$3.02M |
|
45
Kodiak Sciences
KOD
$456M
| $1.5M | 0.28% |
401,540
-40,267
| -9% | -$150K |
|
46
Delcath Systems
DCTH
$384M
| $1.4M | 0.26% |
103,026
-88,444
| -46% | -$1.2M |
|
47
Mersana Therapeutics
MRSN
$36.6M
| $926K | 0.17% |
3,128,421
+39,916
| +1% | +$11.8K |
|
|
RADX
48
Radiopharm Theranostics Limited American Depositary Shares
RADX
$42.8M
| $870K | 0.16% |
187,406
| – | – |
|
49
Modular Medical
MODD
$39.3M
| $529K | 0.1% |
710,363
-248,518
| -26% | -$185K |
|
50
Praxis Precision Medicines
PRAX
$945M
| $421K | 0.08% |
10,000
-156,074
| -94% | -$6.56M |
|